Annual Total Liabilities
$13.05 M
+$4.97 M+61.57%
December 31, 2023
Summary
- As of February 7, 2025, MLTX annual total liabilities is $13.05 million, with the most recent change of +$4.97 million (+61.57%) on December 31, 2023.
- During the last 3 years, MLTX annual total liabilities has fallen by -$8.28 million (-38.82%).
- MLTX annual total liabilities is now -38.82% below its all-time high of $21.33 million, reached on December 31, 2021.
Performance
MLTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$22.71 M
+$7.87 M+52.98%
September 30, 2024
Summary
- As of February 7, 2025, MLTX quarterly total liabilities is $22.71 million, with the most recent change of +$7.87 million (+52.98%) on September 30, 2024.
- Over the past year, MLTX quarterly total liabilities has increased by +$7.87 million (+52.98%).
- MLTX quarterly total liabilities is now at all-time high.
Performance
MLTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
MLTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.6% | +53.0% |
| 3 y3 years | -38.8% | +6.5% |
| 5 y5 years | -38.8% | +6.5% |
MLTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.8% | +61.6% | at high | +486.0% |
| 5 y | 5-year | -38.8% | +61.6% | at high | +486.0% |
| alltime | all time | -38.8% | +61.6% | at high | +486.0% |
MoonLake Immunotherapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.71 M(+53.0%) |
| Jun 2024 | - | $14.85 M(+26.6%) |
| Mar 2024 | - | $11.73 M(-10.1%) |
| Dec 2023 | $13.05 M | $13.05 M(+23.4%) |
| Sep 2023 | - | $10.58 M(+40.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $7.51 M(-2.3%) |
| Mar 2023 | - | $7.68 M(-4.9%) |
| Dec 2022 | $8.08 M(-62.1%) | $8.08 M(+34.1%) |
| Sep 2022 | - | $6.02 M(+55.4%) |
| Jun 2022 | - | $3.88 M(-81.8%) |
| Dec 2021 | $21.33 M | $21.33 M |
FAQ
- What is MoonLake Immunotherapeutics annual total liabilities?
- What is the all time high annual total liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual total liabilities year-on-year change?
- What is MoonLake Immunotherapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly total liabilities year-on-year change?
What is MoonLake Immunotherapeutics annual total liabilities?
The current annual total liabilities of MLTX is $13.05 M
What is the all time high annual total liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual total liabilities is $21.33 M
What is MoonLake Immunotherapeutics annual total liabilities year-on-year change?
Over the past year, MLTX annual total liabilities has changed by +$4.97 M (+61.57%)
What is MoonLake Immunotherapeutics quarterly total liabilities?
The current quarterly total liabilities of MLTX is $22.71 M
What is the all time high quarterly total liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly total liabilities is $22.71 M
What is MoonLake Immunotherapeutics quarterly total liabilities year-on-year change?
Over the past year, MLTX quarterly total liabilities has changed by +$7.87 M (+52.98%)